Mirikizumab for the treatment of chronic antibiotic-refractory pouchitis
Zeitschrift für Gastroenterologie · 01.03.2025 · 63 (03) · 269-272
DOI: 10.1055/a-2404-4518 ↗Kurz gefasst
Fallbericht in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.03.2025. Verfasst von Johannes Reiner und 4 weiteren Autor:innen. Beteiligte Einrichtung: Abteilung für Gastroenterologie und Endokrinologie, Zentrum für Innere Medizin, Universitätsmedizin Rostock, Rostock, Germany. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Antibodies, Monoclonal, Humanized, Colitis, Ulcerative, Pouchitis. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
The current standard of care for the definitive surgical treatment of complicative ulcerative colitis is a continence-preserving proctocolectomy with the creation of an ileal pouch anal anastomosis. In addition to structural and functional disorders, pouchitis of the J-pouch is a common phenomenon, typically well responsive to antimicrobial therapy. However, sometimes chronic antibiotic-refractory pouchitis occurs, most often due to not completely understood multifactorial pathomechanisms. While high-quality evidence is available only for anti-integrin therapy, the role of advanced therapy, i.e., cytokine-antibodies or small molecules in the treatment of chronic antibiotic-refractory pouchitis (CARP), is emerging. This case demonstrates a successful induction treatment of CARP with the novel p19-selective IL-23-targeted antibody mirikizumab.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Abteilung für Gastroenterologie und Endokrinologie, Zentrum für Innere Medizin, Universitätsmedizin Rostock, Rostock, Germany.
- Institut für Pathologie, Universitätsmedizin Rostock, Rostock, Germany.
- Klinik und Poliklinik für Allgemein-, Viszeral-, Thorax-, Gefäß- und Transplantationschirurgie, Universitätsmedizin Rostock, Rostock, Germany.
ORCID-Profile: Johannes Reiner
Zitieren
APA
Reiner, J., Becker, A. S., Huth, A., Lamprecht, G., & Witte, M. (2025). Mirikizumab for the treatment of chronic antibiotic-refractory pouchitis. Zeitschrift für Gastroenterologie, 63(03), 269-272. https://doi.org/10.1055/a-2404-4518
Vancouver
Reiner J, Becker AS, Huth A, Lamprecht G, Witte M. Mirikizumab for the treatment of chronic antibiotic-refractory pouchitis. Zeitschrift für Gastroenterologie. 2025;63(03):269-272. doi:10.1055/a-2404-4518
BibTeX
@article{Reiner2025,
author = {Reiner, Johannes and Becker, Anne-Sophie and Huth, Astrid and Lamprecht, Georg and Witte, Maria},
title = {Mirikizumab for the treatment of chronic antibiotic-refractory pouchitis},
journal = {Zeitschrift für Gastroenterologie},
year = {2025},
volume = {63},
number = {03},
pages = {269--272},
doi = {10.1055/a-2404-4518}
}
EUVIMED